Meeting India’s immunisation goals

This requires sustainable use of resources, timely execution of strategies and total participation from all stakeholders

Date: 18/10/2017

Unleashing the potential of technology in intelligent vaccine management

Date: 29/08/2017

Rapid processes for purification of capsular polysaccharides from Neisseria meningitidis serogroups A and C

Date: 14/09/2015

Development and characterization of Haemophilus influenzae type b conjugate vaccine prepared using different polysaccharide chain lengths

Date: 22/05/2015

Synthesis of a tetrasaccharide and its glycoconjugate corresponding to the capsular polysaccharide of Neisseria meningitidis serogroup X and its immunochemical studies

Date: 22/05/2015

A Forgotten Pioneer of Vaccines

Date: 24/09/2013

Making New Vaccines Affordable

Making new vaccines affordable: a comparison of financing processes used to develop and deploy new meningococcal and pneumococcal conjugate vaccines (Lancet 2011; 378: 1885–93)

Date: 24/09/2013

JSTOR: The Journal of Infectious Diseases, Vol. 174 (Sep., 1996), pp. S118-S124

Rotavirus infection produces a serious health burden in the United States, causing an estimated > 100,000 hospitalizations and >100 deaths annually.

Date: 24/09/2013